Physician profile
Robert J Levy
NPI 1922020759
$6,037.76
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,515 · 2021: $1,245 · 2022: $40.66 · 2024: $1,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Travel and Lodging: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.52 |
| Travel and Lodging | $481.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,500.00 | 2019 | |
| Biotronik Nro, INC. | $1,237.30 | 2024 | Prospera |
| Abbott Laboratories | $1,200.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.99 | 2019-2021 | |
| Ardelyx, INC. | $40.66 | 2022 | |
| Axonics, INC. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.